Small RNA binding exonuclease protection factor La like 4, pseudogene (SSBL4P)

Small RNA binding exonuclease protection factor La like 4, pseudogene (SSBL4P) is a pseudogene, meaning it is a nonfunctional segment of DNA that resembles a functional gene but does not produce a functional protein product. Pseudogenes often arise through processes such as gene duplication or retrotransposition but lose their protein-coding ability due to mutations or lack of regulatory sequences. As a pseudogene, SSBL4P is not considered a therapeutic target, and no biological function or clinical role has been established for it. Is SSBL4P a therapeutic target? No. As a pseudogene, SSBL4P does not encode a functional protein and is not known to participate in any biological pathways amenable to pharmacological modulation. Is there anything incorrect about this target? Yes. SSBL4P is not a typical therapeutic target; it is classified as a pseudogene. In drug discovery and molecular biology, pseudogenes are generally not considered actionable targets due to their lack of protein product or regulatory roles (except in rare cases where pseudogenes may have acquired secondary regulatory functions, which is not established for SSBL4P). Summary: SSBL4P is a pseudogene without known functional, clinical, or therapeutic significance. It is not a protein-coding gene, and there are no known interactions with drugs, no established biomarker status, and no known safety concerns or disease roles. Its inclusion in structured target databases should be flagged as non-actionable and possibly incorrect in any structured therapeutic target list unless novel, specific functional evidence emerges.

Other names

SSBL4PENSG00000230832 (Ensembl)441904 (NCBI Gene ID)HGNC:54985

Not applicable